Technology for the control of DM1. Does it contribute to emotional well-being?

Authors

  • Iñaki Lorente Psychologist, Navarra Diabetes Association, Spain

DOI:

https://doi.org/10.47196/diab.v56i3Sup.591

Keywords:

diabetes mellitus, technology, emotions

Abstract

Recent years have seen a sharp increase in the development of new technologies applied to type-1 diabetes. New apps help us manage it, and we have new ways of administering insulin and measuring glucose1.

Diabetes is the template for the self-managed pathology, since most decisions must be taken by the person with diabetes in “real time”. In that regard, technology poses invaluable help.

Author Biography

Iñaki Lorente, Psychologist, Navarra Diabetes Association, Spain

Psychologist

References

I. Sánchez VV. Nuevas tecnologías aplicadas en el tratamiento de la diabetes mellitus tipo 1. NPunto 2021;4(44):75-97.

II. The WHOQOL Group. The development of the World Health Organization Quality of Life Assessment Instrument (the WHOQOL). In: Orley J., Kuyken W. (eds) Quality of Life Assessment: International Perspectives 1994. Springer, Berlin, Heidelberg. doi: 10.1007/978-3-642-79123-9_4.

III. Ormaechea NL, Campoamor MB, et al. Relationship between quality of life, metabolic control, insulin treatment modality, and glycemic monitoring, in type 1 diabetes mellitus. Rev Esp Endocrinol Pediatr 2019;10(2):60-68.

IV. Ritholz M. Is continuous glucose monitoring for everyone? Consideration of psychosocial factors. Diabetes Spectrum 2008;21(4):287-289.

Downloads

Published

2022-09-01

How to Cite

Lorente, I. (2022). Technology for the control of DM1. Does it contribute to emotional well-being?. Journal of the Argentine Society of Diabetes, 56(3Sup), 92–92. https://doi.org/10.47196/diab.v56i3Sup.591

Issue

Vol. 56 No. 3Sup (2022): September/December 2022

Section

Technology applied to psychosocial aspects in type 1 diabetes mellitus

License

Copyright (c) 2022 on behalf of the authors. Reproduction rights: Argentine Diabetes Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.